Healthcare $3.7B yearly AI spending outpaces other industries

The news: Spending on healthcare AI surged 2.5X over the past year to $3.7 billion, according to a new Menlo Ventures report based on a survey of 550 executives at healthcare providers, health plans, and pharma/biotech companies. The $3.7 billion outlay is more than double the next-largest sector, legal ($1.8 billion), and exceeds the entire vertical AI market a year earlier ($3.5 billion), per Menlo. Spending refers to purchases of AI products and solutions, not acquisitions of AI companies. Other verticals analyzed include creators, government, and financial services.

Provider organizations account for 77% of healthcare AI spending in the past year. This includes medical scribes that turn patient visits into clinical documentation, AI-powered coding and billing, and patient engagement and front-office tools.

Pharma makes up 19% of healthcare AI spending. It’s the fastest-growing subsegment. Spending skyrocketed from $30 million to $700 million in the past year, with the biggest gains coming from AI drug discovery investments.

Payers account for just 4% of the sector’s AI spending. Health insurers’ AI investment is largely reactive, driven by advances in AI use among providers and the need to comply with new regulation, per Menlo.

Why it matters: Healthcare has become the leading market for industry-specific AI tools, reflecting both the sector’s enormous administrative burden and the potential for the tech to streamline complex, labor-intensive workflows. For hospitals and health systems, that largely means reducing administrative waste, which accounts for 15% to 30% of US healthcare spending, and freeing clinicians to focus on patient care. For pharma, AI offers a way to shorten costly drug development timelines and increase the odds of bringing a drug to market.

Healthcare organizations are also seeing returns on AI investments faster than expected, likely reflecting the sector’s sizable opportunity to improve operational efficiency. AI deployments are paying off in about one year, half the time executives initially anticipated, per a recent Bessemer Venture Partners and Bain & Company survey. About 40% of use cases exceeded expectations, while 54% generated “material ROI” within the first year.

Implications for AI companies: Healthcare rewards AI vendors that can build solutions tailored to the industry's complex workflows, regulatory requirements, and data systems. Half of healthcare AI spending goes to industry-specific applications, more than double the 24% share across enterprises overall, per Menlo.

At the same time, general-purpose AI players like Google and OpenAI are expanding their healthcare offerings, intensifying competition for specialized vendors. Those vendors have traditionally relied on their industry expertise and grasp of healthcare customers’ unique needs. AI companies that can integrate seamlessly with existing systems, demonstrate measurable returns, and minimize implementation burdens will be best positioned to capture healthcare AI budgets.

This content is part of EMARKETER’s subscription Briefings, where we pair daily updates with data and analysis from forecasts and research reports. Our Briefings prepare you to start your day informed, to provide critical insights in an important meeting, and to understand the context of what’s happening in your industry. Not a subscriber? Click here to get a demo of our full platform and coverage.

You've read 0 of 2 free articles this month.

Get more articles - create your free account today!